disease

Renal Cell Carcinoma

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Renal Cell Carcinoma: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

166Connections

0Hypotheses

0Analyses

47Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

Disease Info

Associated Genes	APOPTOSIS, BAP1, CANCER, CDKN2A, DNA, GENES, IL6, INFLAMMATION
KG Connections	155 knowledge graph edges
Databases	OMIM Orphanet ClinicalTrials PubMed

Pathway Diagram

graph TD
    Renal_Cell_Carcinoma["Renal Cell Carcinoma"] -->|"activates"| Oxidative_Stress["Oxidative Stress"]
    Renal_Cell_Carcinoma["Renal Cell Carcinoma"] -->|"associated"| Metastasis["Metastasis"]
    Renal_Cell_Carcinoma["Renal Cell Carcinoma"] -->|"therapeutic target"| Apoptosis["Apoptosis"]
    Renal_Cell_Carcinoma["Renal Cell Carcinoma"] -->|"regulates"| Carcinoma["Carcinoma"]
    Renal_Cell_Carcinoma["Renal Cell Carcinoma"] -->|"activates"| Carcinoma_1["Carcinoma"]
    Renal_Cell_Carcinoma["Renal Cell Carcinoma"] -->|"therapeutic target"| Carcinoma_2["Carcinoma"]
    Tumor["Tumor"] -.->|"inhibits"| Renal_Cell_Carcinoma["Renal Cell Carcinoma"]
    VHL["VHL"] -->|"activates"| Renal_Cell_Carcinoma["Renal Cell Carcinoma"]
    HIF["HIF"] -->|"activates"| Renal_Cell_Carcinoma["Renal Cell Carcinoma"]
    CANCER["CANCER"] -->|"activates"| Renal_Cell_Carcinoma["Renal Cell Carcinoma"]
    style Renal_Cell_Carcinoma fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (47)

Target	Relation	Type	Str
Metastasis	associated_with	pathway	0.70
Oxidative Stress	activates	pathway	0.70
Apoptosis	therapeutic_target	pathway	0.70
brain metastases	causes	disease	0.70
Carcinoma	therapeutic_target	disease	0.65
Carcinoma	regulates	disease	0.65
Carcinoma	activates	disease	0.65
Mtor	regulates	pathway	0.60
Drug Resistance	therapeutic_target	pathway	0.60
Glycolysis	regulates	pathway	0.60
Pi3K/Akt	inhibits	pathway	0.60
Mtor	inhibits	pathway	0.60
Apoptosis	inhibits	pathway	0.60
Cell Cycle	inhibits	pathway	0.60
Angiogenesis	inhibits	pathway	0.60
Autophagy	inhibits	pathway	0.60
Ferroptosis	activates	pathway	0.60
Homologous Recombination	activates	pathway	0.60
Metastasis	therapeutic_target	pathway	0.60
Pi3K/Akt	therapeutic_target	pathway	0.60
Oxidative Stress	therapeutic_target	pathway	0.60
Mtor	treats	pathway	0.60
Pyroptosis	activates	pathway	0.60
Immunotherapy	activates	pathway	0.60
Mtor	activates	pathway	0.60
Mapk	activates	pathway	0.60
Tumor Microenvironment	activates	pathway	0.60
Receptor Tyrosine Kinase	inhibits	pathway	0.60
Stem Cell	activates	pathway	0.60
Apoptosis	associated_with	pathway	0.60
Carcinoma	associated_with	disease	0.55
Als	activates	disease	0.55
Carcinoma	causes	disease	0.55
Carcinoma	expressed_in	disease	0.55
Lymphoma	treats	disease	0.55
Carcinoma	treats	disease	0.55
Als	treats	disease	0.55
Inflammation	associated_with	disease	0.55
Arrhythmia	activates	disease	0.55
Als	associated_with	disease	0.55
NEUTROPHILS	activates	concept	0.50
MTOR	associated_with	gene	0.50
NRF2	associated_with	gene	0.45
NIVOLUMAB	associated_with	drug	0.45
SUNITINIB	associated_with	drug	0.45
IPILIMUMAB	associated_with	drug	0.45
HO-1	associated_with	gene	0.45

Incoming (119)

Source	Relation	Type	Str
IL-6	promotes	protein	0.85
Ferroptosis	associated_with	process	0.85
Tumor	activates	disease	0.75
VHL	activates	gene	0.75
HIF	activates	gene	0.75
CANCER	activates	gene	0.75
Tumor	inhibits	disease	0.75
APOPTOSIS	therapeutic_target	gene	0.75
PIEZO1	therapeutic_target	gene	0.75
ferroptosis	implicated_in	process	0.70
RICTOR	therapeutic_target	gene	0.65
AKT	therapeutic_target	gene	0.65
MTOR	treats	gene	0.65
MITOCHONDRIAL DYSFUNCTION	therapeutic_target	gene	0.65
OXIDATIVE STRESS	therapeutic_target	gene	0.65
RAPTOR	therapeutic_target	gene	0.65
PI3K	therapeutic_target	gene	0.65
BCL-2	therapeutic_target	gene	0.65
JAK2	therapeutic_target	gene	0.65
VHL	therapeutic_target	gene	0.65
EPO	therapeutic_target	gene	0.65
DNA	associated_with	gene	0.65
Cancer	associated_with	disease	0.65
CANCER	associated_with	gene	0.65
APOPTOSIS	inhibits	gene	0.65
MMP9	associated_with	gene	0.65
APOPTOSIS	associated_with	gene	0.65
GENES	associated_with	gene	0.65
PI3K	inhibits	gene	0.65
CANCER	inhibits	gene	0.65
Carcinoma	inhibits	disease	0.65
INFLAMMATION	associated_with	gene	0.65
IL6	associated_with	gene	0.65
TP53	associated_with	gene	0.65
MTOR	inhibits	gene	0.65
AKT	inhibits	gene	0.65
AKT	regulates	gene	0.65
MTOR	regulates	gene	0.65
ATG14L	inhibits	gene	0.65
BECLIN1	inhibits	gene	0.65
AUTOPHAGY	inhibits	gene	0.65
CDKN2A	activates	gene	0.65
OXIDATIVE STRESS	activates	gene	0.65
BRCA1	activates	gene	0.65
BRCA2	activates	gene	0.65
FERROPTOSIS	activates	gene	0.65
MITOCHONDRIA	activates	gene	0.65
MITOCHONDRIAL DYSFUNCTION	activates	gene	0.65
DNA	activates	gene	0.65
ROS	activates	gene	0.65

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Renal Cell Carcinoma in their description or question text

No additional research found